Topiramate Capsule, Extended Release
Product Images NDC 27241-229

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 27241-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (Topiramate 100mg)

FDA Label Image

200mg (Topiramate 200mg)

FDA Label Image

25mg (Topiramate 25mg)

FDA Label Image

50mg (Topiramate 50mg)

FDA Label Image

Figure1 (Topiramate Figure1)

This text appears to represent cumulative rates for time to first seizure. The numbers listed indicate the rates at different time intervals. There are two groups represented, one receiving Topiramate 50 mg/day and the other receiving Topiramate 400 mg/day, with their respective sample sizes mentioned. The values range from 0.00 to 0.50. However, without further context or additional information, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

Figure2 (Topiramate Figure2)

FDA Label Image

Structure (Topiramate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.